ACADIA PHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Acadia Pharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Acadia Pharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 166M shares, a 1.45% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 166M +2.38M +1.45% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 166M +2.5M +1.53% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 165M +2.58M +1.59% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 165M +2.59M +1.6% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 164M +2.1M +1.3% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 163M +1.51M +0.94% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 162M +1M +0.62% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 162M +1.05M +0.65% Dec 31, 2022 10-K 2024-02-28
Q3 2022 162M +1.18M +0.74% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 162M +1.22M +0.76% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 161M +1.21M +0.76% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 161M +1.37M +0.86% Dec 31, 2021 10-K 2023-02-28
Q3 2021 161M +1.83M +1.15% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 161M +3.24M +2.06% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 160M +4.73M +3.04% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 160M +4.36M +2.81% Dec 31, 2020 10-K 2022-03-01
Q3 2020 159M +5.32M +3.47% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 157M +12.9M +8.95% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 155M +11.3M +7.85% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 155M +11.4M +7.94% Dec 31, 2019 10-K 2021-02-25
Q3 2019 154M +28.5M +22.8% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 144M +19.5M +15.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 144M +19.3M +15.5% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 144M +19.4M +15.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 125M +2.31M +1.88% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 125M +2.66M +2.18% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 125M +2.81M +2.31% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 124M +3.04M +2.51% Dec 31, 2017 10-K 2019-02-27
Q3 2017 123M +1.61M +1.33% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 122M +8.65M +7.61% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 122M +9.21M +8.17% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 121M +19.4M +19.1% Dec 31, 2016 10-K 2018-02-27
Q3 2016 121M +20.2M +20% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 114M +13.2M +13.1% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 113M +12.5M +12.5% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 102M +1.89M +1.89% Dec 31, 2015 10-K 2017-02-28
Q3 2015 101M +1.19M +1.2% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 101M +1.22M +1.23% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 100M +1.45M +1.46% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 100M +8.94M +9.82% Dec 31, 2014 10-K 2016-02-29
Q3 2014 99.7M +10.7M +12.1% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 99.3M +15.9M +19% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 98.8M +25.4M +34.6% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 91.1M +17.8M +24.2% Dec 31, 2013 10-K 2015-02-26
Q3 2013 89M +32.4M +57.2% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 83.4M +30.4M +57.3% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 73.5M +20.5M +38.8% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 73.3M +20.4M +38.6% Dec 31, 2012 10-K 2014-02-27
Q3 2012 56.6M +3.79M +7.18% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 53M +230K +0.44% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 52.9M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 52.9M +13.5M +34.4% Dec 31, 2011 10-K 2013-03-12
Q3 2011 52.8M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 52.8M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 39.4M Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.